Aclarion secures $10.4M for back-pain diagnostic technology
Aclarion Inc. (Nasdaq: ACON) recently raised $10.4 million through a stock sale, funding that extends the Broomfield-based health-care technology company’s operating runway into 2028, as it works to expand insurance coverage for its advanced imaging decision support tool for chronic back pain.